En vivo
BioWorldViva in vivo! At EHA, in vivo CAR T data continues to impressIlluminaWhat is proteomics? A simple guide to understanding measuring proteins at scale - IlluminaFritsch GmbHWorld Laser Diffraction Optical Units - Market Analysis, Forecast, Size, Trends and Insights - IndexBoxTSI IncorporatedHot Wire Anemometers Market Growth Outlook to 2035: Innovation and Regulatory Tailwinds - News and Statistics - IndexBoxNovo NordiskNovo Nordisk’s CagriSema Breakthrough Expands Growth Story Beyond Diabetes and Obesity - simplywall.stMKS NewportCenters Receive Awards for Nanoscale Research | light speed | Feb 2002 - Photonics SpectraEurofinsEurofins Scientific SE Stock (FR0014000MR3): stock in focus after quiet trading week - AD HOC NEWSCellMechanism of lipid transfer by bridge-like protein VPS13A and the scramblase XKCellGregory J. Hannon (1964–2026)10x Genomics NewsCanaccord reiterates Buy on 10X Genomics stock after acquisition By Investing.com - Investing.com NigeriaFierceBiotechLilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’Eli LillyLilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting - investor.lilly.com
Endpoints News 30 abr 2026

Lack of specifics on obesity pill sales hover over Lilly’s first quarter

Lack of specifics on obesity pill sales hover over Lilly’s first quarter

Contenido no disponible. Consulta la fuente original.